News in brief: Biosimilar switching letters cause concern; MBS item for EMR removal of very large sessile colorectal polyps; Screen for obsessive eating in GI disorders

Biosimilar switching letters cause concern Pharmacists have raised concerns about some gastroenterologists who they claim are giving patients proforma letters supplied by Abbvie insisting that the originator Humira brand of adalimumab is dispensed rather than biosimilars. According to a report in The Australian, pharmacists said they felt it was inappropriate for doctors to use letter ...

Already a member?

Login to keep reading.

© 2021 the limbic